On the Prognostic Implications of Nuclear Atypia in Bethesda III Thyroid Nodules
Cytopathology · 2026-09 · 37 (5) · 566-567
DOI: 10.1111/cyt.70084 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cytopathology, online erschienen am 03.05.2026. Verfasst von Yusuf Öztürk. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Sakarya Training and Research Hospital, Sakarya, Turkey. Hauptthemen laut MEDLINE: Thyroid Nodule, Cell Nucleus, Thyroid Neoplasms. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Nuclear atypia has been proposed as a useful criterion for subclassifying thyroid nodules with atypia of undetermined significance (AUS), with potential implications for malignancy risk. In our analysis of nodules initially classified as AUS and subsequently confirmed as malignant, clinical outcomes were generally favourable and did not differ according to the presence of nuclear atypia. These findings suggest that while nuclear atypia may have diagnostic relevance, its prognostic impact may be limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Sakarya Training and Research Hospital, Sakarya, Turkey.
ORCID-Profile: Yusuf Öztürk
Zitieren
APA
Öztürk, Y. (2026). On the Prognostic Implications of Nuclear Atypia in Bethesda III Thyroid Nodules. Cytopathology, 37(5), 566-567. https://doi.org/10.1111/cyt.70084
Vancouver
Öztürk Y. On the Prognostic Implications of Nuclear Atypia in Bethesda III Thyroid Nodules. Cytopathology. 2026;37(5):566-567. doi:10.1111/cyt.70084
BibTeX
@article{ztrk2026,
author = {Öztürk, Yusuf},
title = {On the Prognostic Implications of Nuclear Atypia in Bethesda III Thyroid Nodules},
journal = {Cytopathology},
year = {2026},
volume = {37},
number = {5},
pages = {566--567},
doi = {10.1111/cyt.70084}
}
EUVIMED